Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

Sponsor
University of British Columbia
Study ID
NCT07581288
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Endometrial Cancer
  • Endometrial Hyperplasia
  • Endometrial Intraepithelial Neoplasia
  • Menstrual Cycle
  • Reproductive Endocrinology
  • Uterine Bleeding
  • Uterine Cancer
  • Uterine Neoplasms

Eligibility Criteria

Sex
FEMALE
Age
35 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.

Key Dates

Start date
May 31, 2026
Status verified
Apr 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: MIRA Participants
    Individuals aged 35 or older who have experienced abnormal uterine bleeding.

Primary Outcome Measure

Urinary Hormone Levels (Mira Monitor) [ Time Frame: 3 months ]

Related Studies